Trade Names: | |
Synonyms: | |
Status: | Approved (2016) |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | L01XC27 |
UNII: | TT6HN20MVF |
Primary Target | |
---|---|
platelet derived growth factor receptor alpha |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Sarcoma | 4 | D012509 | ClinicalTrials |
Neoplasms | 4 | D009369 | ClinicalTrials |
Sarcoma | 4 | D012509 | FDA |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Gastrointestinal Stromal Tumors | 2 | D046152 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
Neoplasm Metastasis | 1 | D009362 | ClinicalTrials |
Leiomyosarcoma | 1 | D007890 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1024603-93-7 |
ChEMBL | CHEMBL1743049 |
FDA SRS | TT6HN20MVF |
Guide to Pharmacology | 9172 |